Urticaria and angioedema: An overview

Immunology and Allergy Clinics of North America

Volumn 24, Issue 2, 2004, Pages 141-162

  Dibbern Jr , Donald A ^a   Dreskin, Stephen C ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; CIMETIDINE; COLCHICINE; CONTRAST MEDIUM; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; CYPROHEPTADINE; DAPSONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXEPIN; FEXOFENADINE; GOLD; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; RANITIDINE; SALAZOSULFAPYRIDINE; STEROID; UNINDEXED DRUG; VANCOMYCIN; WARFARIN; ZAFIRLUKAST; ZILEUTON;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; CHRONIC URTICARIA; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INCREASED APPETITE; LOW DRUG DOSE; MEDICAL SPECIALIST; META ANALYSIS; PATHOGENICITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; SYSTEMIC DISEASE; URTICARIA; WEIGHT GAIN;

EID: 2142821391     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2004.01.008     Document Type: Review

References (157)

1. Sheldon J.M., Mathews K.P., Lovell R.G. The vexing urticaria problem: present concepts of etiology and management. J Allergy 1954;25:525-60.
2. Heberden W. Of the nettle rash. Medical Transactions 1772;2:173.
3. Sun S. Qain-jin-yao-fang. 3rd edition. Taipei (Taiwan): Freedom Publishers; 1982 [in Chinese].
4. Schwartz LB, Huff TF. Biology of mast cells. In: Middleton Jr E, Ellis EF, Adkinson Jr NF, Yunginger JW, Busse WW, editors. Allergy: principles and practice. St. Louis: Mosby; 1998. p. 261-76.
5. Beltrani V.S. Urticaria and angioedema. Dermatol Clin 1996;14:171-98.
6. Mathews K.P. Urticaria and angioedema. J Allergy Clin Immunol 1983;72:1-14.
7. Lindelof B., Sigurgeirsson B., Wahlgren C.F., Eklund G. Chronic urticaria and cancer: an epidemiological study of 1155 patients. Br J Dermatol 1990;123:453-6.
8. Humphreys F., Hunter J.A. The characteristics of urticaria in 390 patients. Br J Dermatol 1998;138:635-8.
9. O'Donnell B.F., Lawlor F., Simpson J., Morgan M., Greaves M.W. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997;136:197-201.
10. Poon E., Seed P.T., Greaves M.W., Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999;140:667-71.
11. Baiardini I., Giardini A., Pasquali M., Dignetti P., Guerra L., Specchia C., et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 2003;58:621-3.
12. Russell P.S. Dermatology in the Oregon plan with implications for health care plans in other states. Arch Dermatol 1994;130:709-12.
13. Green G.R., Koelsche G.A., Kierland R.R. Etiology and pathogenesis of chronic urticaria. Ann Allergy 1965;23:30-6.
14. Champion R.H., Roberts S.O., Carpenter R.G., Roger J.H. Urticaria and angio-oedema: a review of 554 patients. Br J Dermatol 1969;81:588-97.
15. Harris A., Twarog F.J., Geha R.S. Chronic urticaria in childhood: natural course and etiology. Ann Allergy 1983;51:161-5.
16. Quaranta J.H., Rohr A.S., Rachelefsky G.S., Siegel S.C., Katz R.M., Spector S.L., et al. The natural history and response to therapy of chronic urticaria and angioedema. Ann Allergy 1989;62:421-4.
17. Mullins R.J., Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol 2002;88:42-51.
18. Sugiura M., Hayakawa R., Kato Y., Sugiura K., Hashimoto R. Results of patch testing with lavender oil in Japan. Contact Dermatitis 2000;43:157-60.
19. Carson C.F., Riley T.V. Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil. Contact Dermatitis 2001;45:65-7.
20. Knight T.E., Hausen B.M. Melaleuca oil (tea tree oil) dermatitis. J Am Acad Dermatol 1994;30:423-7.
21. Hayashi K., Kawachi S., Saida T. Allergic contact dermatitis due to both chlorpheniramine maleate and dibucaine hydrochloride in an over-the-counter medicament. Contact Dermatitis 2001;44:38-9.
22. Heine A. Diphenhydramine: a forgotten allergen? Contact Dermatitis 1996;35:311-2.
23. Coskey R.J. Contact dermatitis caused by diphenhydramine hydrochloride. J Am Acad Dermatol 1983;8:204-6.
24. Schafer T., Bohler E., Ruhdorfer S., Weigl L., Wessner D., Filipiak B., et al. Epidemiology of contact allergy in adults. Allergy 2001;56:1192-6.
25. Henderson R.L. Jr., Fleischer A.B. Jr., Feldman S.R. Allergists and dermatologists have far more expertise in caring for patients with urticaria than other specialists. J Am Acad Dermatol 2000;43:1084-91.
26. Joint Task Force on Practice Parameters The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema. Part II: chronic urticaria/angioedema. Ann Allergy Asthma Immunol 2000;85:521-44.
27. Grattan C., Powell S., Humphreys F. Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 2001;144:708-14.
28. Kulp-Shorten C.L., Callen J.P. Urticaria, angioedema, and rheumatologic disease. Rheum Dis Clin North Am 1996;22:95-115.
29. Dahl M.V. Clinical pearl: diascopy helps diagnose urticarial vasculitis. J Am Acad Dermatol 1994;30:481-2.
30. Charlesworth E. The spectrum of urticaria. Immunol Allergy Clin North Am 1995;15:641-57.
31. Veznor J. B.S., Huston D.P. Urticarial vasculitis. Immunol Allergy Clin North Am 1995;15:761-74.
32. Davis M.D., Brewer J.D. Urticarial vasculitis. Immunol Allergy Clin North Am 2004;24:183-213.
33. Vazquez-Lopez F., Maldonado-Seral C., Soler-Sanchez T., Perez-Oliva N., Marghoob A.A. Surface microscopy for discriminating between common urticaria and urticarial vasculitis. Rheumatology (Oxford) 2003;42:1079-82.
34. Greaves M.W. Chronic urticaria. N Engl J Med 1995;332:1767-72.
35. Soter N.A. Acute and chronic urticaria and angioedema. J Am Acad Dermatol 1991;25:146-54.
36. Kikuchi Y., Kaplan A.P. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002;109:114-8.
37. Kaplan AP. Urticaria and angioedema. In: Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER, editors. Middleton's allergy: principles and practice. 6th ed. Philadelphia: Mosby; 2003. p. 1537-58.
38. Frigas E., Nzeako U.C. Angioedema: pathogenesis, differential diagnosis, and treatment. Clin Rev Allergy Immunol 2002;23:217-31.
39. Greaves M.W., Sabroe R.A. ABC of allergies. Allergy and the skin. I - Urticaria. BMJ 1998;316:1147-50.
40. Grattan C. Autoimmune urticaria. Immunol Allergy Clin North Am 2004;24:163-81.
41. Dice J. Physical urticaria. Immunol Allergy Clin North Am 2004;24:225-46.
42. Kozel M.M., Mekkes J.R., Bossuyt P.M., Bos J.D. Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 2001;45:387-91.
43. Wong R.C., Fairley J.A., Ellis C.N. Dermographism: a review. J Am Acad Dermatol 1984;11:643-52.
44. Casale T.B., Sampson H.A., Hanifin J., Kaplan A.P., Kulczycki A., Lawrence I.D., et al. Guide to physical urticarias. J Allergy Clin Immunol 1988;82:758-63.
45. Hirschmann J.V., Lawlor F., English J.S., Louback J.B., Winkelmann R.K., Greaves M.W. Cholinergic urticaria: a clinical and histologic study. Arch Dermatol 1987;123:462-7.
46. Moore-Robinson M., Warin R.P. Some clinical aspects of cholinergic urticaria. Br J Dermatol 1968;80:794-9.
47. Grant R.T. P.R., Comeau W.J. Observations on urticaria provoked by emotion, by exercise and by warming the body. Clin Sci 1935;2:253-72.
48. Wanderer A.A., Hoffman H.M. The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am 2004;24:259-86.
49. Lawlor F. Delayed pressure urticaria. Immunol Allergy Clin North Am 2004;24:247-58.
50. Dover J.S., Black A.K., Ward A.M., Greaves M.W. Delayed pressure urticaria: clinical features, laboratory investigations, and response to therapy of 44 patients. J Am Acad Dermatol 1988;18:1289-98.
51. Sussman G.L., Harvey R.P., Schocket A.L. Delayed pressure urticaria. J Allergy Clin Immunol 1982;70:337-42.
52. Schafer C. Physical urticaria. Immunol Allergy Clin North Am 1995;15:679-99.
53. Lawlor F., Black A.K., Breathnach A.S., Greaves M.W. Vibratory angioedema: lesion induction, clinical features, laboratory and ultrastructural findings and response to therapy. Br J Dermatol 1989;120:93-9.
54. Chalamidas S.L., Charles C.R. Aquagenic urticaria. Arch Dermatol 1971;104:541-6.
55. Luong K.V., Nguyen L.T. Aquagenic urticaria: report of a case and review of the literature. Ann Allergy Asthma Immunol 1998;80:483-5.
56. Gruber B.L., Baeza M.L., Marchese M.J., Agnello V., Kaplan A.P. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988;90:213-7.
57. Hide M., Francis D.M., Grattan C.E., Hakimi J., Kochan J.P., Greaves M.W. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria [see comments]. N Engl J Med 1993;328:1599-604.
58. Greaves M. Autoimmune urticaria. Clin Rev Allergy Immunol 2002;23:171-83.
59. Sabroe R.A., Fiebiger E., Francis D.M., Maurer D., Seed P.T., Grattan C.E., et al. Classification of anti-FcεRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002;110:492-9.
60. Asero R. Sex differences in the pathogenesis of chronic urticaria. J Allergy Clin Immunol 2003;111:425-6.
61. Leznoff A., Sussman G.L. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989;84:66-71.
62. Kikuchi Y., Fann T., Kaplan A.P. Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol 2003;112:218.
63. Lopez L.R., Davis K.C., Kohler P.F., Schocket A.L. The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine. J Allergy Clin Immunol 1984;73:600-3.
64. Mehregan D.R., Hall M.J., Gibson L.E. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992;26:441-8.
65. Leznoff A., Josse R.G., Denburg J., Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983;119:636-40.
66. Zauli D., Grassi A., Ballardini G., Contestabile S., Zucchini S., Bianchi F.B. Thyroid autoimmunity in chronic idiopathic urticaria: implications for therapy. Am J Clin Dermatol 2002;3:525-8.
67. Stafford C.T. Urticaria as a sign of systemic disease. Ann Allergy 1990;64:264-70.
68. Rumbyrt J.S., Schocket A.L. Chronic urticaria and thyroid disease. Immunol Allergy Clin North Am 2004;24:215-23.
69. Vaughn M.P., DeWalt A.C., Diaz J.D. Urticaria associated with systemic disease and psychological factors. Immunol Allergy Clin North Am 1995;15:725-43.
70. Pasricha J.S., Pasricha A., Prakash O.M. Role of gastro-intestinal parasites in urticaria. Ann Allergy 1972;30:348-51.
71. Schnyder B., Helbling A., Pichler W.J. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol 1999;119:60-3.
72. Jacobson K.W., Branch L.B., Nelson H.S. Laboratory tests in chronic urticaria. JAMA 1980;243:1644-6.
73. Reinhold U., Bruske T., Schupp G. Paraneoplastic urticaria in a patient with ovarian carcinoma. J Am Acad Dermatol 1996;35:988-9.
74. Worm M., Kolde G. Schnitzler's syndrome: successful treatment of two patients using thalidomide. Br J Dermatol 2003;148:601-2.
75. DeVillez R.L. Urticaria pigmentosa. Immunol Allergy Clin North Am 1995;15:775-84.
76. Metcalfe DD. Mastocytosis syndromes. In: Adkinson NF YJ, Busse WW, Bochner BS, Holgate ST, Simons FER, editors. Middleton's allergy: principles and practice. 6th ed. Philadelphia: Mosby; 2003. p. 1523-36.
77. Brockow K. Urticaria pigmentosa. Immunol Allergy Clin North Am 2004;24:287-316.
78. Sabroe R.A., Seed P.T., Francis D.M., Barr R.M., Black A.K., Greaves M.W. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999;40:443-50.
79. Sanchez-Borges M., Capriles-Hulett A., Caballero-Fonseca F. Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs. Clin Rev Allergy Immunol 2003;24:125-36.
80. Grimm V., Rakoski J., Ring J. Urticaria and angioedema induced by COX-2 inhibitors. J Allergy Clin Immunol 2002;109:370.
81. Kelkar P.S., Butterfield J.H., Teaford H.G. Urticaria and angioedema from cyclooxygenase-2 inhibitors. J Rheumatol 2001;28:2553-4.
82. Bhalla M., Thami G.P. Delayed diagnosis of angiotensin-converting enzyme (ACE) inhibitor induced angioedema and urticaria. Clin Exp Dermatol 2003;28:333-4.
83. Howard P.J., Lee M.R. Beware beta-adrenergic blockers in patients with severe urticaria! Scott Med J 1988;33:344-5.
84. Bagnato G.F., De Pasquale R., Giacobbe O., Chirico G., Ricciardi L., Gangemi S., et al. Urticaria in a tattooed patient. Allergol Immunopathol (Madr) 1999;27:32-3.
85. England R.W., Vogel P., Hagan L. Immediate cutaneous hypersensitivity after treatment of tattoo with Nd:YAG laser: a case report and review of the literature. Ann Allergy Asthma Immunol 2002;89:215-7.
86. Ashinoff R., Levine V.J., Soter N.A. Allergic reactions to tattoo pigment after laser treatment. Dermatol Surg 1995;21:291-4.
87. Wai Y.C., Sussman G.L. Evaluating chronic urticaria patients for allergies, infections, or autoimmune disorders. Clin Rev Allergy Immunol 2002;23:185-93.
88. Pecquet C., Leynadier F., Dry J. Contact urticaria and anaphylaxis to natural latex. J Am Acad Dermatol 1990;22:631-3.
89. Wrangsjo K., Wahlberg J.E., Axelsson I.G. IgE-mediated allergy to natural rubber in 30 patients with contact urticaria. Contact Dermatitis 1988;19:264-71.
90. Kozel M.M., Mekkes J.R., Bossuyt P.M., Bos J.D. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 1998;134:1575-80.
91. Kozel M.M., Bossuyt P.M., Mekkes J.R., Bos J.D. Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review. J Am Acad Dermatol 2003;48:409-16.
92. Tharp M.D. Chronic urticaria: pathophysiology and treatment approaches. J Allergy Clin Immunol 1996;98:S325-30.
93. Zavadak D., Tharp M.D. Chronic urticaria as a manifestation of the late phase reaction. Immunol Allergy Clin North Am 1995;15:745-59.
94. Sabroe R.A., Grattan C.E., Francis D.M., Barr R.M., Kobza Black A., Greaves M.W. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999;140:446-52.
95. Sabroe R.A., Poon E., Orchard G.E., Lane D., Francis D.M., Barr R.M., et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Allergy Clin Immunol 1999;103:484-93.
96. Ying S., Kikuchi Y., Meng Q., Kay A.B., Kaplan A.P. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002;109:694-700.
97. Grattan C.E., Francis D.M., Hide M., Greaves M.W. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991;21:695-704.
98. Tong L.J., Balakrishnan G., Kochan J.P., Kinet J.P., Kaplan A.P. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997;99:461-5.
99. O'Donnell B.F., O'Neill C.M., Francis D.M., Niimi N., Barr R.M., Barlow R.J., et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999;140:853-8.
100. Shiekh J. Advances in the treatment of chronic urticaria. Immunol Allergy Clin North Am 2004;24:317-34.
101. Finn A.F. Jr., Kaplan A.P., Fretwell R., Qu R., Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1999;104:1071-8.
102. Leurs R., Church M.K., Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 2002;32:489-98.
103. DuBuske L.M. Basophils, cytokines, and the allergic inflammatory response. Allergy Asthma Proc 1996;17:3-4.
104. Wanderer A.A., St Pierre J.P., Ellis E.F. Primary acquired cold urticaria: double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo. Arch Dermatol 1977;113:1375-7.
105. Sigler R.W., Evans R. 3rd, Horakova Z., Ottesen E., Kaplan A.P. The role of cyproheptadine in the treatment of cold urticaria. J Allergy Clin Immunol 1980;65:309-12.
106. Kennard C.D. Evaluation and treatment of urticaria. Immunol Allergy Clin North Am 1995;15:785-801.
107. Ormerod A.D. Urticaria. Recognition, causes and treatment. Drugs 1994;48:717-30.
108. Stanaland B.E. Treatment of patients with chronic idiopathic urticaria. Clin Rev Allergy Immunol 2002;23:233-41.
109. Fox R.W. Chronic urticaria: mechanisms and treatment. Allergy Asthma Proc 2001;22:97-100.
110. Zuberbier T., Greaves M.W., Juhlin L., Merk H., Stingl G., Henz B.M. Management of urticaria: a consensus report. J Investig Dermatol Symp Proc 2001;6:128-31.
111. Zuberbier T., Munzberger C., Haustein U., Trippas E., Burtin B., Mariz S.D., et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology 1996;193:324-7.
112. Kawashima M., Harada S., Tango T. Review of fexofenadine in the treatment of chronic idiopathic urticaria. Int J Dermatol 2002;41:701-6.
113. Kaplan A.P. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002;346:175-9.
114. Harvey R.P., Wegs J., Schocket A.L. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol 1981;68:262-6.
115. Bleehen S.S., Thomas S.E., Greaves M.W., Newton J., Kennedy C.T., Hindley F., et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol 1987;117:81-8.
116. Paul E., Bodeker R.H. Treatment of chronic urticaria with terfenadine and ranitidine: a randomized double-blind study in 45 patients. Eur J Clin Pharmacol 1986;31:277-80.
117. Soter N.A. Urticaria: current therapy. J Allergy Clin Immunol 1990;86:1009-14.
118. Richelson E. Tricyclic antidepressants and histamine H1 receptors. Mayo Clin Proc 1979;54:669-74.
119. Richelson E. Antimuscarinic and other receptor-blocking properties of antidepressants. Mayo Clin Proc 1983;58:40-6.
120. Schwartz L.B. Mast cells and their role in urticaria. J Am Acad Dermatol 1991;25:190-204.
121. Ryan JJ, Huff TF. Biology of mast cells. In: Adkinson NF YJ, BusseWW, Bochner BS, Holgate ST, Simons FER, editors. Middleton's allergy: principles and practice. 6th ed. Philadelphia: Mosby; 2003. p. 333-46.
122. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002;110:484-8.
123. Spector S., Tan R.A. Antileukotrienes in chronic urticaria. J Allergy Clin Immunol 1998;101:572.
124. Ellis M.H. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 1998;102:876-7.
125. Perez C., Sanchez-Borges M., Capriles E. Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J Allergy Clin Immunol 2001;108:1060-1.
126. Elliott G.R., Lauwen A.P., Bonta I.L. Prostaglandin E2 inhibits and indomethacin and aspirin enhance, A23187-stimulated leukotriene B4 synthesis by rat peritoneal macrophages. Br J Pharmacol 1989;96:265-70.
127. Anand M.K. N.H., Dreskin S.C. A possible role for cyclooxygenase 2 inhibitors in the treatment of chronic urticaria. J Allergy Clin Immunol 2003;115:1133-6.
128. Boehncke W.H., Ludwig R.J., Zollner T.M., Ochsendorf F., Kaufmann R., Gibbs B.F. The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria. Br J Dermatol 2003;148:604-6.
129. Toth-Kasa I., Jancso G., Obal F. Jr., Husz S., Simon N. Involvement of sensory nerve endings in cold and heat urticaria. J Invest Dermatol 1983;80:34-6.
130. Grattan C.E., O'Donnell B.F., Francis D.M., Niimi N., Barlow R.J., Seed P.T., et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000;143:365-72.
131. Kennes B., De Maubeuge J., Delespesse G. Treatment of chronic urticaria with a β2-adrenergic stimulant. Clin Allergy 1977;7:35-9.
132. Spangler D.L., Vanderpool G.E., Carroll M.S., Tinkelman D.G. Terbutaline in the treatment of chronic urticaria. Ann Allergy 1980;45:246-7.
133. Bressler R.B., Sowell K., Huston D.P. Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial. J Allergy Clin Immunol 1989;83:756-63.
134. Lawlor F., Ormerod A.D., Greaves M.W. Calcium antagonist in the treatment of symptomatic dermographism. Low-dose and high-dose studies with nifedipine. Dermatologica 1988;177:287-91.
135. Nurnberg W., Grabbe J., Czarnetzki B.M. Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol 1995;75:54-6.
136. Wiles J.C., Hansen R.C., Lynch P.J. Urticarial vasculitis treated with colchicine. Arch Dermatol 1985;121:802-5.
137. Gach J.E., Sabroe R.A., Greaves M.W., Black A.K. Methotrexate-responsive chronic idiopathic urticaria: a report of two cases. Br J Dermatol 2001;145:340-3.
138. Weiner M.J. Methotrexate in corticosteroid-resistant urticaria. Ann Intern Med 1989;110:848.
139. Stack P.S. Methotrexate for urticarial vasculitis. Ann Allergy 1994;72:36-8.
140. Jaffer A.M. Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol 1991;88:964-5.
141. Engler R.J., Squire E., Benson P. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol 1995;74:155-9.
142. Handfield-Jones S.E., Greaves M.W. Urticarial vasculitis-response to gold therapy. J R Soc Med 1991;84:169.
143. Wong E., Eftekhari N., Greaves M.W., Ward A.M. Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol 1987;116:553-6.
144. Parsad D., Pandhi R., Juneja A. Stanozolol in chronic urticaria: a double blind, placebo controlled trial. J Dermatol 2001;28:299-302.
145. Parslew R., Pryce D., Ashworth J., Friedmann P.S. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy 2000;30:1161-5.
146. Bernstein J.A., Garramone S.M., Lower E.G. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide. Ann Allergy Asthma Immunol 2002;89:212-4.
147. Worm M., Sterry W., Kolde G. Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis. Br J Dermatol 2000;143:1324.
148. Grattan C.E., Francis D.M., Slater N.G., Barlow R.J., Greaves M.W. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992;339:1078-80.
149. O'Donnell B.F., Barr R.M., Black A.K., Francis D.M., Kermani F., Niimi N., et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998;138:101-6.
150. Zackheim H.S. The FDA guidelines for the treatment of psoriasis using cyclosporine A: are they adequate? Cutis 2002;70:288-90.
151. Fradin M.S., Ellis C.N., Goldfarb M.T., Voorhees J.J. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 1991;25:1065-7.
152. Li L., Ding J. Treatment of urticaria with cupping at back-shu points - a report of 40 cases. J Tradit Chin Med 2001;21:37-8.
153. Chen C.J., Yu H.S. Acupuncture treatment of urticaria. Arch Dermatol 1998;134:1397-9.
154. Fried R.G. Nonpharmacologic treatments in psychodermatology. Dermatol Clin 2002;20:177-85.
155. Shenefelt P.D. Hypnosis in dermatology. Arch Dermatol 2000;136:393-9.
156. Shertzer C.L., Lookingbill D.P. Effects of relaxation therapy and hypnotizability in chronic urticaria. Arch Dermatol 1987;123:913-6.
157. Bressler R. Pathophysiology of chronic urticaria. Immunol Allergy Clin North Am 1995;15:659-77.